What are the benefits and risks of using ACE inhibitors or ARBs in lupus patients taking hydroxychloroquine?
Abstract
Hydroxychloroquine offers significant benefits in managing SLE and lupus nephritis, whereas ACE inhibitors and ARBs provide additional renal and cardiovascular protections. However, evidence on their combined effects in lupus is limited.
Fields of Study & Subjects
Drug-Induced Ocular Toxicity
Systemic Lupus Erythematosus Research
Cerebral Venous Sinus Thrombosis
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 2 January 2026